University Health System researchers discovered they could prevent diabetes from recurring in diabetic mice by transplanting insulin-manufacturing islet cells and then administering an anti-inflammatory drug called Lisofylline, according to a University Health System press release.
Researchers knew that transplantation was promising in treating type 1 diabetes. But the body destroyed islet cells without immune system-suppressing drugs.
The newly-created drug Lisofylline prevents cell destruction without the need for immune suppressants.
Researchers said their next step will be to test the drug in humans who have received islet cell transplants.
Read More
From the Archives: Celebration and Reflection (4/28 - 5/4)
By Clara Franklin and Annabelle Nee | 4 hours agoFrom The Purple Shadows breaking into the Dean of Students’s office to multiple student athletes accused of honor code violations, the graduating class’s four years were a wild ride.
PBS NewsHour correspondent speaks on bringing humanity to international conflict
By Grace Little | YesterdaySchifrin's work exploring Putin’s Russia, his coverage of COVID-19 and his reporting in Afghanistan and Ukraine have earned him various accolades.
Spring meal swipe drive aims to tackle food insecurity at the University
By Nicolas Biernacki | YesterdayU.Va. Dine facilitated the drive by converting each meal swipe donated by a student into one pound of food that is then donated to the CFP.
